Skip to main content

Find a clinical trial

Find a clinical trial

Trial status
Trial Phase
Trial type
14 clinical trials grid list download
  • Titre Organe Phase Statut Crittères majeurs d'inclusion Contact
  • 1367.1 An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit Multiples phase 1 Ouvert any line, RECIST 1.1 Ahmad Hussein Awada
  • AMC303-01 A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin Multiples phase 1/1b Fermé any line, RECIST 1.1 Philippe Aftimos
  • BOS172738 A Phase 1 Study of BOS172738 in Patients with Advanced Solid Tumors with RET Gene Alterations including Non-Small Cell Lung Cancer (NSCLC) and Medullary Thyroid Cancer (MTC) Multiples phase 1 Ouvert Rearranged during transfection(RET) gene altered malignancy Christiane Jungels
  • EORTC 1209-EnTF A phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients with either differentiated or medullary thyroid cancer progressing after first line therapy Thyroïde phase 2 Fermé At least 1 or 2 prior lines of treatment Yassine Lalami
  • EORTC 1658 Qualification of imaging methods to assess cancer drug induced interstitial lung disease (ImageILD) Poumon Fermé any line / Lung metastasis Konstantinos Stathopoulos
  • I7W-MC-JQBA A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors Multiples phase 1 Fermé RECIST 1.1, after standard trerapy Ahmad Hussein Awada
  • IJB_2728 Improving emotion regulation for patients with metastatic cancer: A pilot study assessing the impact of a multi-component psychological group intervention Tumeurs solides Ouvert Metastatic, any tumors
  • Intervention destinée aux parents L'enfant face au cancer d'un parent: une étude randomisée évaluant l'efficacité d'une intervention psychologique destinée à soutenir la parentalité Tumeurs solides Ouvert Be a parent or close relative of a child between the ages of 3 and 18 confronted with parental cancer, any tumors
  • MCLA-158-CL01 Phase 1 dose escalation and cohort expansion study evaluating single-agent MCLA-158 in metastatic colorectal cancer and other advanced solid tumors Multiples phase 1 Ouvert Metastatic, Biopsy mandatory Christiane Jungels
  • NIS-OBE-CAP-2013/1 Caprelsa(r) Registry : A Belgian Registry to evaluate the use of Vandetanib (Caprelsa(r)) in current clinical practice Thyroïde Fermé Already received a prescription for vandeanib Ahmad Hussein Awada
  • OX2016-203-01 An open-label, dose-escalation, phase I study to assess the safety, pharmacokinetics and pharmacodynamics of AsiDNA, a DNA repair inhibitor administered intravenously in patients with advanced solid tumors Multiples phase 1 Ouvert Any line/RECIST v1.1/Eligible for platinium salt chemotherapy Nuria Kotecki
  • Sevrage Tabagique Impact of an emotion and craving regulation intervention on smoking cessation and maintenance among oncology patients : a randomized study Tumeurs solides Ouvert Smoker of quit smoking within the last 6 months, any tumors
  • SYD985.004 A two-part phase I study with the antibody-drug conjugate SYD985 in combination with niraparib to evaluate safety, pharmacokinetics and efficacy in patients with HER2-expressing locally advanced or metastatic solid tumours Multiples phase 1 Ouvert RECIST v1.1 Philippe Aftimos
  • XL184-311 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy Thyroïde phase 3 Ouvert RECIST 1.1 Yassine Lalami